The University of Chicago Header Logo

Connection

Robert Naclerio to Patient Reported Outcome Measures

Back to Details
This is a "connection" page, showing publications Robert Naclerio has written about Patient Reported Outcome Measures.
Robert Naclerio
Connection Strength
0.080
Patient Reported Outcome Measures
  1. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020 01; 75(1):148-157.
    View in: PubMed
    Score: 0.041
  2. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.